We're taking profits on a drugmaker, raising price target and adding to a cybersecurity stock

The recent leg higher in shares of this drugmaker came around its first-quarter earnings report Thursday.

from US Top News and Analysis https://ift.tt/Wl6ScG0
https://ift.tt/vDelXr9